| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 16,293 | 15,506 | 15,798 | 16,806 | | Cost of Revenue | 5,019 | 4,894 | 5,024 | 5,219 | | | Gross Profit | 11,274 | 10,612 | 10,774 | 11,587 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,728 | 7,379 | 7,305 | 6,986 | | Non Recurring | 308 |
-
| (4,968) | 4,968 | | Others | 4,656 | 916 | 6,158 | 750 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,418) | 2,317 | 2,279 | (1,117) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,518) | 2,317 | 2,279 | (1,117) | | Interest Expense | 1,445 | 1,475 | 1,619 | 1,597 | | Income Before Tax | (2,963) | 842 | 660 | (2,714) | | Income Tax Expense | (1,092) | 119 | (1,554) | 355 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,771) | 723 | 2,214 | (3,069) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,771) | 723 | 2,214 | (3,069) | | Preferred Stock And Other Adjustments | (372) | (342) |
-
|
-
| | | Net Income Applicable To Common Shares | ($2,143) | $381 | $2,214 | ($3,069) |
|
0.11% Nasdaq 0.00%
Income Statement
